Literature DB >> 26740662

Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity.

Wendy M Walwyn1, Wenling Chen2, Hyeyoung Kim3, Ani Minasyan1, Helena S Ennes3, James A McRoberts3, Juan Carlos G Marvizón4.   

Abstract

Many chronic pain disorders alternate between bouts of pain and periods of remission. The latent sensitization model reproduces this in rodents by showing that the apparent recovery ("remission") from inflammatory or neuropathic pain can be reversed by opioid antagonists. Therefore, this remission represents an opioid receptor-mediated suppression of a sustained hyperalgesic state. To identify the receptors involved, we induced latent sensitization in mice and rats by injecting complete Freund's adjuvant (CFA) in the hindpaw. In WT mice, responses to mechanical stimulation returned to baseline 3 weeks after CFA. In μ-opioid receptor (MOR) knock-out (KO) mice, responses did not return to baseline but partially recovered from peak hyperalgesia. Antagonists of α2A-adrenergic and δ-opioid receptors reinstated hyperalgesia in WT mice and abolished the partial recovery from hyperalgesia in MOR KO mice. In rats, antagonists of α2A adrenergic and μ-, δ-, and κ-opioid receptors reinstated hyperalgesia during remission from CFA-induced hyperalgesia. Therefore, these four receptors suppress hyperalgesia in latent sensitization. We further demonstrated that suppression of hyperalgesia by MORs was due to their constitutive activity because of the following: (1) CFA-induced hyperalgesia was reinstated by the MOR inverse agonist naltrexone (NTX), but not by its neutral antagonist 6β-naltrexol; (2) pro-enkephalin, pro-opiomelanocortin, and pro-dynorphin KO mice showed recovery from hyperalgesia and reinstatement by NTX; (3) there was no MOR internalization during remission; (4) MORs immunoprecipitated from the spinal cord during remission had increased Ser(375) phosphorylation; and (5) electrophysiology recordings from dorsal root ganglion neurons collected during remission showed constitutive MOR inhibition of calcium channels. SIGNIFICANCE STATEMENT: Chronic pain causes extreme suffering to millions of people, but its mechanisms remain to be unraveled. Latent sensitization is a phenomenon studied in rodents that has many key features of chronic pain: it is initiated by a variety of noxious stimuli, has indefinite duration, and pain appears in episodes that can be triggered by stress. Here, we show that, during latent sensitization, there is a sustained state of pain hypersensitivity that is continuously suppressed by the activation of μ-, δ-, and κ-opioid receptors and by adrenergic α2A receptors in the spinal cord. Furthermore, we show that the activation of μ-opioid receptors is not due to the release of endogenous opioids, but rather to its ligand-independent constitutive activity.
Copyright © 2016 the authors 0270-6474/16/360204-18$15.00/0.

Entities:  

Keywords:  adrenergic receptor; constitutive activity; hyperalgesia; kappa-opioid receptor; latent sensitization; mu-opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 26740662      PMCID: PMC4701961          DOI: 10.1523/JNEUROSCI.1751-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  75 in total

1.  MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli.

Authors:  R C Spike; Z Puskár; H Sakamoto; W Stewart; C Watt; A J Todd
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

2.  alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes.

Authors:  X Li; J C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

3.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

4.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

5.  Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain.

Authors:  L R Gardell; M Ibrahim; R Wang; Z Wang; M H Ossipov; T P Malan; F Porreca; J Lai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

6.  Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.

Authors:  Juan Carlos G Marvizón; Wenling Chen; Niall Murphy
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

7.  Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.

Authors:  Mei Xu; Michael Petraschka; Jay P McLaughlin; Ruth E Westenbroek; Marc G Caron; Robert J Lefkowitz; Traci A Czyzyk; John E Pintar; Gregory W Terman; Charles Chavkin
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

8.  Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.

Authors:  Ivy Carroll; James B Thomas; Linda A Dykstra; Arthur L Granger; Richard M Allen; James L Howard; Gerald T Pollard; Mario D Aceto; Louis S Harris
Journal:  Eur J Pharmacol       Date:  2004-10-06       Impact factor: 4.432

Review 9.  Neuropathic pain: the paradox of dynorphin.

Authors:  J Lai; M H Ossipov; T W Vanderah; T P Malan; F Porreca
Journal:  Mol Interv       Date:  2001-08

10.  Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce micro-opioid receptor internalization in the rat spinal cord.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

View more
  28 in total

1.  Recent advances toward understanding the mysteries of the acute to chronic pain transition.

Authors:  Theodore J Price; Pradipta R Ray
Journal:  Curr Opin Physiol       Date:  2019-06-04

2.  Enhanced Postsynaptic GABAB Receptor Signaling in Adult Spinal Projection Neurons after Neonatal Injury.

Authors:  Chelsie L Brewer; Mark L Baccei
Journal:  Neuroscience       Date:  2018-06-07       Impact factor: 3.590

Review 3.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

4.  Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.

Authors:  Jami L Saloman; Nicole N Scheff; Lindsey M Snyder; Sarah E Ross; Brian M Davis; Michael S Gold
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

5.  Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.

Authors:  Lilian Custodio-Patsey; Renée R Donahue; Weisi Fu; Joshua Lambert; Bret N Smith; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-07-25       Impact factor: 5.250

6.  Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.

Authors:  Wenling Chen; Helena S Ennes; James A McRoberts; Juan Carlos Marvizón
Journal:  Neuropharmacology       Date:  2017-10-16       Impact factor: 5.250

Review 7.  The development of pain circuits and unique effects of neonatal injury.

Authors:  Chelsie L Brewer; Mark L Baccei
Journal:  J Neural Transm (Vienna)       Date:  2019-08-09       Impact factor: 3.575

8.  Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain.

Authors:  Wenling Chen; Yvette Taché; Juan Carlos Marvizón
Journal:  Neuroscience       Date:  2018-06-15       Impact factor: 3.590

9.  Neuropeptide Y tonically inhibits an NMDAR➔AC1➔TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain.

Authors:  Weisi Fu; Caitlin R Wessel; Bradley K Taylor
Journal:  Neuropeptides       Date:  2020-01-24       Impact factor: 3.286

10.  Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve-injured mice.

Authors:  Miriam Martínez-Navarro; David Cabañero; Agnieszka Wawrzczak-Bargiela; Anne Robe; Claire Gavériaux-Ruff; Brigitte L Kieffer; Ryszard Przewlocki; Josep E Baños; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2020-02-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.